{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T05:53:12Z","timestamp":1740894792570,"version":"3.38.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"DOI":"10.7759\/cureus.79889","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T18:42:31Z","timestamp":1740854551000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunophenotypic Shift From CD8 to CD4 With Anaplastic Lymphoma Kinase (ALK)-Negative Anaplastic Large Cell Transformation in Mycosis Fungoides: A Case Report"],"prefix":"10.7759","author":[{"given":"Timothy H","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagmohan S","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-016-0594-9","article-title":"Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover","volume":"39","author":"Krejsgaard T","year":"2017","unstructured":"Krejsgaard T, Lindahl LM, Mongan NP, et al.. Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover. Semin Immunopathol. 2017, 39:269-82. 10.1007\/s00281-016-0594-9","journal-title":"Semin Immunopathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14723","article-title":"Immunophenotypic shift from CD4+ to CD8+ in mycosis fungoides","volume":"175","author":"Endo C","year":"2016","unstructured":"Endo C, Naka Y, Miyagaki T, Fujita H, Sugaya M, Kawashima M, Tsunemi Y. Immunophenotypic shift from CD4+ to CD8+ in mycosis fungoides. Br J Dermatol. 2016, 175:830-3. 10.1111\/bjd.14723","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.02.035","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma","volume":"62","author":"Gormley RH","year":"2010","unstructured":"Gormley RH, Hess SD, Anand D, Junkins-Hopkins J, Rook AH, Kim EJ. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma. J Am Acad Dermatol. 2010, 62:300-7. 10.1016\/j.jaad.2009.02.035","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.144.8.1027","article-title":"CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement","volume":"144","author":"Introcaso CE","year":"2008","unstructured":"Introcaso CE, Kim EJ, Gardner J, Junkins-Hopkins JM, Vittorio CC, Rook AH. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement. Arch Dermatol. 2008, 144:1027-9. 10.1001\/archderm.144.8.1027","journal-title":"Arch Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14689","article-title":"CD8+ cytotoxic mycosis fungoides: a retrospective analysis of clinical features and follow-up results of 29 patients","volume":"59","author":"Kalay Yildizhan I","year":"2020","unstructured":"Kalay Yildizhan I, Sanli H, Akay BN, S\u00fcrg\u00fcn E, Heper A. CD8+ cytotoxic mycosis fungoides: a retrospective analysis of clinical features and follow-up results of 29 patients. Int J Dermatol. 2020, 59:127-33. 10.1111\/ijd.14689","journal-title":"Int J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11107","article-title":"Cytotoxic\/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force workshop","volume":"97","author":"Santucci M","year":"2003","unstructured":"Santucci M, Pimpinelli N, Massi D, et al.. Cytotoxic\/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force workshop. Cancer. 2003, 97:610-27. 10.1002\/cncr.11107","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.12.1692","article-title":"Immunophenotypic shift in a case of mycosis fungoides with vitreous invasion","volume":"118","author":"Lois N","year":"2000","unstructured":"Lois N, Hiscott PS, Nash J, Wong D. Immunophenotypic shift in a case of mycosis fungoides with vitreous invasion. Arch Ophthalmol. 2000, 118:1692-4. 10.1001\/archopht.118.12.1692","journal-title":"Arch Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12252","article-title":"Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases","volume":"41","author":"Aung PP","year":"2014","unstructured":"Aung PP, Climent F, Muzzafar T, et al.. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases. J Cutan Pathol. 2014, 41:51-7. 10.1111\/cup.12252","journal-title":"J Cutan Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05015.x","article-title":"Isolation of a CD8\u03b1\u03b1+ CD4- tumour T\u2010cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T\u2010cell lymphoma","volume":"148","author":"Nikolova M","year":"2003","unstructured":"Nikolova M, Echchakir H, Wechsler J, Boumsell L, Bensussan A, Bagot M. Isolation of a CD8\u03b1\u03b1+ CD4- tumour T\u2010cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T\u2010cell lymphoma. Br J Dermatol. 2003, 148:24-9. 10.1046\/j.1365-2133.2003.05015.x","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14026","article-title":"Immunophenotypic switch in cutaneous T-cell lymphoma: a series of three cases and review of the literature","volume":"48","author":"Bitar C","year":"2021","unstructured":"Bitar C, Hile G, Brown NA, et al.. Immunophenotypic switch in cutaneous T-cell lymphoma: a series of three cases and review of the literature. J Cutan Pathol. 2021, 48:986-94. 10.1111\/cup.14026","journal-title":"J Cutan Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000786","article-title":"Immunophenotypic shifts in primary cutaneous \u03b3\u03b4 T-cell lymphoma suggest antigenic modulation: a study of sequential biopsy specimens","volume":"41","author":"Agbay RL","year":"2017","unstructured":"Agbay RL, Torres-Cabala CA, Patel KP, et al.. Immunophenotypic shifts in primary cutaneous \u03b3\u03b4 T-cell lymphoma suggest antigenic modulation: a study of sequential biopsy specimens. Am J Surg Pathol. 2017, 41:431-45. 10.1097\/PAS.0000000000000786","journal-title":"Am J Surg Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12112","article-title":"Phenotypic evolution in a case of peripheral T-cell lymphoma suggests the presence of tumor heterogeneity","volume":"40","author":"Al-Ibraheemi A","year":"2013","unstructured":"Al-Ibraheemi A, Kanagal-Shamanna R, Patel KP, Konoplev SN, Mehta P, Medeiros LJ, Miranda RN. Phenotypic evolution in a case of peripheral T-cell lymphoma suggests the presence of tumor heterogeneity. J Cutan Pathol. 2013, 40:573-9. 10.1111\/cup.12112","journal-title":"J Cutan Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0290","article-title":"Brentuximab vedotin","volume":"19","author":"Deng C","year":"2013","unstructured":"Deng C, Pan B, O'Connor OA. Brentuximab vedotin. Clin Cancer Res. 2013, 19:22-7. 10.1158\/1078-0432.CCR-12-0290","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","article-title":"Mycosis fungoides and Sezary syndrome","volume":"88","author":"Diamandidou E","year":"1996","unstructured":"Diamandidou E, Cohen PR, Kurzrock R. Mycosis fungoides and Sezary syndrome. Blood. 1996, 88:2385-409.","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0000000000000166","article-title":"Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors","volume":"46","author":"Pulitzer M","year":"2014","unstructured":"Pulitzer M, Myskowski PL, Horwitz SM, Querfeld C, Connolly B, Li J, Murali R. Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors. Pathology. 2014, 46:610-6. 10.1097\/PAT.0000000000000166","journal-title":"Pathology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000047","article-title":"Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous","volume":"22","author":"Xing X","year":"2015","unstructured":"Xing X, Feldman AL. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous. Adv Anat Pathol. 2015, 22:29-49. 10.1097\/PAP.0000000000000047","journal-title":"Adv Anat Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow SH","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016, 127:2375-90. 10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2024.2733","article-title":"Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma","volume":"20","author":"Gleason L","year":"2024","unstructured":"Gleason L, Afifi L, Banner L, et al.. Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma. Mol Clin Oncol. 2024, 20:35. 10.3892\/mco.2024.2733","journal-title":"Mol Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000000375","article-title":"Characterization of primary cutaneous CD8+\/CD30+ lymphoproliferative disorders","volume":"37","author":"Martires KJ","year":"2015","unstructured":"Martires KJ, Ra S, Abdulla F, Cassarino DS. Characterization of primary cutaneous CD8+\/CD30+ lymphoproliferative disorders. Am J Dermatopathol. 2015, 37:822-33. 10.1097\/DAD.0000000000000375","journal-title":"Am J Dermatopathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15860","article-title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma","volume":"186","author":"Hapgood G","year":"2019","unstructured":"Hapgood G, Ben-Neriah S, Mottok A, et al.. Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma. Br J Haematol. 2019, 186:e28-31. 10.1111\/bjh.15860","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/303029-immunophenotypic-shift-from-cd8-to-cd4-with-anaplastic-lymphoma-kinase-alk-negative-anaplastic-large-cell-transformation-in-mycosis-fungoides-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T18:42:33Z","timestamp":1740854553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/303029-immunophenotypic-shift-from-cd8-to-cd4-with-anaplastic-lymphoma-kinase-alk-negative-anaplastic-large-cell-transformation-in-mycosis-fungoides-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.79889","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}